Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

** DIABETES MANAGEMENT CERTIFICATION PROGRAM


Date: Mar 3, 2021 01:00 AM - Mar 1, 2024 01:00 AM

Fee

$0.00

CE Hours

18.00

CE Units

1.800

Registration closes on Mar 01, 2024 01:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1 – ADA Indications for Statins in Diabetes – Roy Eldor, MD 
 
Article #2 - Guideline Updates:  What’s new in the ADA and AACE/ ACE Guidelines – Doug Jones, MD  

Objectives

  • List the differences between the 2019 ADA and AACE national guidelines for the management of type 1 and type 2 diabetes and how they differ in approach from previous guidelines
  • Explain the latest recommendation for the management of type 2 diabetes patients with renal failure
  • Describe the latest recommendations for the management of type 2 diabetes patients with cardiovascular disease
  • Describe the latest recommendations for the management of type 2 diabetes patients with hemoglobin A1C greater than 9%.

Speaker(s)/Author(s)

Ola Odugbesan, MD, MRCP, FACE, MD, MRCP, FACE

Activity Number

0010-0000-21-026-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 

Article #1 - Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline - Guillermo E. Umpierrez,

Article #2 - Outpatient Management of Pediatric Type 1 Diabetes- Joni K Beck, Pharm.D.

Article #3 - Approaches to rapid-acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets – Alexandra Migdal

Article #4 - Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update from the American College of Physicians – Amir Qaseem, MD, PhD, MHA

Article #5 - An update on SGLT 2 inhibitors for the treatment of Diabetes Mellitus – Daniel S. Hsia

Objectives

  • Recognize diabetes medications that have been demonstrated to have favorable effects on ASCVD risk
  • Describe individualized T2DM therapy based on a clinical understanding of the features of oral and injectable antidiabetic medications and patient-specific needs and preferences.
  • List strategies to overcome barriers to insulin intensification in T2DM, including clinical inertia and the risk of hypoglycemia.
  • Describe patient education and patient-prescriber communication strategies to aid patients in overcoming concerns about insulin intensification and fear of injections, thus increasing patient adherence to therapy and improving clinical outcomes

Speaker(s)/Author(s)

Kendra Lewis, Pharm.D., BC-Adm, CDE, PharmD

Activity Number

0010-0000-21-027-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 

Article #1 - Suitable Use of Injectable Agents to Overcome Hypoglycemic Risk – Willy M. Valencia.

Article #2. Type 2 Diabetes Mellitus: Outpatient insulin Management - Amanda Howard-Thompson, PharmD

Article #3.  Management of hypoglycemia in older adults with type 2 diabetes – Jeffery Freeman.


 

Objectives

  • List the approaches to initiating, switching, and adjusting basal and prandial insulins for improved glycemic control.
  • Describe physician and patient-directed insulin titration strategies used in clinical practice, which are different from those used in type 2 diabetes.
  • Describe practical considerations for initiating therapies other than insulin in type 1 diabetes
  • List the information that continuous glucose monitoring technology provides.

Speaker(s)/Author(s)

Jennifer Elliott, Pharm.D., CDE, BCADP

Activity Number

0010-0000-21-028-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1.  Inappropriate use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases – Virtudes Perez-Jover 
 
Article #2 – The Unmet Challenge of Medication Nonadherence – Fred Kleinsinger MD 

Objectives

  • List the emerging adherence quality drivers and their relevance in your healthcare setting
  • List the five factors that influence patient medication adherence
  • Explain the importance of communication between health professionals and their patients and caregivers
  • List simple strategies, techniques, and resources to support patient engagement

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-034-H05-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1.  Nutritional Strategies for Prevention and Management of Diabetes:  Consensus and Uncertainties – Judith Wylie-Rosetti  
 
Article #2. Paradigm Shifts in Nutrition Therapy for Type 2 Diabetes- Nutrition Therapy for diabetes- Satoru Yamada  

Objectives

  • Explain the nutrient recommendations for the various classifications of diabetes, listing carbohydrate, fiber, protein, and fat amounts
  • Explain the differences between meal planning, energy, and nutrient requirements for type 1 and type 2 diabetes
  • Define the glycemic response, and explain how this concept is applied to the nutritional control of diabetes
  • List three sugar substitutes presently used, and discuss their positive and negative features
  • List several meal-planning approaches explaining the benefits and drawbacks of each
  • Identify the problems and guidelines for use of alcohol, eating out, snacking, hypoglycemic episodes, and sick day management

Speaker(s)/Author(s)

Lamura Poore, RD

Activity Number

0010-0000-21-029-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1.  Current perspectives on cardiovascular outcome trials in diabetes – Oliver Schnell  
 
Article #2. Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials – Deborah Hinnen 
 
Article #3.  Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease and EASD Study Group – Oliver Schnell 

Objectives

  • List the major diabetes outcomes trials (ACCORD, ADVANCE, UKPDS, VADT, Look Ahead) and their key findings
  • Explain the excess risk of cardiovascular disease (CVD) associated with diabetes mellitus compared to nondiabetic patients.
  • Describe the evidence that the use of SGLT2 inhibitors and GLP-1 agonists in diabetic patients is associated with the reduction of CVD.
  • Recognize practical implications of recent findings in EMPA-REG and LEADER trials on current treatment algorithms and future clinical studies

Speaker(s)/Author(s)

James R. Gavin III MD, PhD

Activity Number

0010-0000-21-030-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1. Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus – Gayatri Lessey   
 
Article #2.  Management of diabetic dyslipidemia: An Update – Iswarlal Jialal, MD, PhD  
 
Article #3. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research – Radia Marium Modhumi Khan  

Objectives

  • Describe strategies to optimize the impact of lifestyle interventions in the treatment of diabetes and related conditions
  • List evidence-based treatment strategies on the management and treatment of cardiovascular disease including hypertension, coronary artery disease, and heart failure
  • Identify evidence-based treatment strategies for the management of renal disease and renal disease complications.

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-031-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1. Diabetes Technology Update:  Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital – Guillermo E. Umpierrez MD  
 
Article #2.  Impact of technology-based interventions for children and young people with type 1 diabetes on key diabetes self-management behaviors and prerequisites: a systematic review – Emily C.L. Knox  
 
Article #3. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial - S. N. Parsons 

Objectives

  • Describe how self-monitoring of blood glucose can be used most effectively in patients with type 2 diabetes not taking insulin.
  • Identify when to use CGM data with insulin pump dosing information.
  • Recognize how to integrate CGM data with insulin pump dosing information.
  • Explain how to incorporate mobile applications into diabetes practice.

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-032-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00
   

   

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached. 
 
Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.
 
Article #1 – Culturally tailoring patient education and communication skills training to empower African Americans with diabetes – Monica E. Peek, MD, MPH 

Objectives

  • List the various clinical conditions in which we see disparities in health
  • List the various social and environmental inequities that lead to poor health outcomes
  • Identify the barriers to health literacy.
  • Explain the strategies and techniques to employ cross-cultural communication
  • Describe an understanding of cultural competency using specific examples

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-033-H01-P

Release Date: Mar 4, 2021
Credit Expiration Date: Mar 4, 2024

CE Hours

2.00